EU fidaxomicin approval another feather in Optimer's 2011 cap
13 December 2011
Ian Haydock
Please Login to read the full article.
13 December 2011
Ian Haydock
Please Login to read the full article.
RELATED CONTENT
NEWS
- Optimer signs $90 million-plus deal with Astellas for Dificid in Japan
- CHMP opines positively on Dificlir, hypertension and diabetes combos, but restricts Multaq
- Optimer climbs on US Dificid OK, but all eyes on launch success
- Optimer axes chairman, CFO and VP over misconduct related to stock options
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
